The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Reasons for first-line maintenance therapy discontinuation among patients with newly diagnosed advanced ovarian cancer treated in real-world settings.
 
Jinan Liu
Employment - GlaxoSmithKline
 
Premal H. Thaker
Stock and Other Ownership Interests - Celsion
Consulting or Advisory Role - Aravive; Celsion; Iovance Biotherapeutics; Novocure; Stryker; Tesaro
Speakers' Bureau - AstraZeneca; Merck; Tesaro
Research Funding - GlaxoSmithKline (Inst); Merck (Inst)
 
Janvi Sah
Employment - STATinMED Research
Consulting or Advisory Role - GlaxoSmithKline (Inst)
 
Eric M Maiese
Other Relationship - GlaxoSmithKline
 
Linda Kalilani
Employment - GlaxoSmithKline
 
Rajesh Mallampati
Employment - STATinMED Research
Consulting or Advisory Role - GlaxoSmithKline (Inst)
 
Jean Hurteau
Employment - DuPage Medical Group (I); GlaxoSmithKline
Stock and Other Ownership Interests - DuPage Medical Group (I); GlaxoSmithKline
 
John Chan
Consulting or Advisory Role - Abbvie; Acerta Pharma; Aravive; AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Merck; Roche
Speakers' Bureau - Abbvie; Acerta Pharma; Aravive; AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Merck; Roche
Research Funding - Abbvie; Acerta Pharma; Aravive; AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Merck; Roche